|
Using the company’s biology, chemistry, and commercial development expertise, Radius is focusing on the discovery and development of novel anabolic drugs for metabolic bone diseases and on new drugs for other unmet needs in women’s health. |
|
Core Capabilities |
|
Radius has extensive expertise in bone biology and pharmacology as well as capabilities for identifying and characterizing new drug candidates for the treatment of osteoporosis, symptoms of menopause, and reproductive disorders. Radius has expertise in the chemistry of estrogen and other steroid-receptor ligands and capabilities for broad-scale design, synthesis, and screening for anabolic bone and muscle properties, as well as for other diseases regulated by nuclear hormone receptors. Radius also holds intellectual property related to nuclear hormone receptors. Biology and Pharmacology
candidates against osteoblasts for their ability to affect apoptosis, differentiation, and maturation
bone formation and inflammatory diseases
reproduction, and reproductive disorders associated with inflammation Chemistry
targets
and androgens Development
leading classes of osteoporosis drugs, including bazedoxifene, Fosamax®, and Forteo® Commercialization
including Neupogen® and Primaxin® Research Focus: Goals
bone
drugs Target Areas
disorders
|